Article
Salidroside attenuates cognitive deficits induced by chronic cerebral hypoperfusion via modulating microglial phenotypic transformation in mice.
Journal of neuroimmunology - 15 Mar 2025
Ji Weiwei, Zhang Zengyu, Jin Tingyu, Meng Danyang, Zhou Xuyou, Hu Jin, Wang Yong
Abstract excerpt
BACKGROUND: Chronic cerebral hypoperfusion (CCH) is a significant contributor to vascular cognitive impairment (VCI), often linked to cortical and hippocampal damage. This study investigates the therapeutic potential of salidroside (SLDS) in mitigating CCH-induced brain injury by modulating microglial activation and inflammatory responses. METHODS: We established a CCH model in mice using the 0.16/0.18 mm...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
